The Longevity Week: Master Investor Masterclass
The Investment Panel investigates demonstrated Longevity growth, name-checking some hot areas for investment, seeing how Longevity-ready institutional investors are...
The Longevity Week: Master Investor Masterclass
It was the Longevity Forum's Longevity Week this week and this Science Panel, supported by Master Investor, benchmarks current...
We talk supplementation, neurotech, mitochondrial dysfunction, clinical scale-ups, COVID and CGM with Longevity legend: Dave Asprey
Ahead of Revolution Against Aging and Death conference, which...
Teenage founder of Canadian start-up Biotein hunts a universal phenotype for senescent cells.
As we’ve covered in the past, Biotein’s Nina Khera has a mission...
BioViva and Integrated Health Systems: How many patients in trials? Where are they located? What pipeline stage?
As we've covered in the past, BioViva's Liz...
Forever Healthy Foundation issues risk-benefit analysis on dasatinib + quercetin as a senolytic.
The Forever Healthy Foundation published its latest risk-benefit analysis, which explores the combined...
